Blood Pressure Pill Exforge HCT Approved

Exforge HCT Combines 3 Hypertension Drugs Into 1 Pill

From the WebMD Archives

May 5, 2009 -- The FDA has approved Exforge HCT, which combines three blood pressure drugs -- amlodipine, valsartan, and hydrochlorothiazide -- into one pill.

Amlodipine is a calcium-channel blocker. Valsartan is an angiotensin-receptor blocker (ARB). Hydrochlorothiazide is a diuretic.

In June 2007, the FDA approved Exforge, which contains amlodipine and valsartan. The newly approved Exforge HCT adds hydrochlorothiazide.

The FDA approved Exforge HCT based on a clinical trial that included more than 2,000 patients, according to a news release from Novartis, the drug company that makes Exforge and Exforge HCT.

Novartis plans to offer Exforge and Exforge HCT at the same price in the U.S.

WebMD Health News Reviewed by Louise Chang, MD on May 05, 2009

Sources

SOURCES:

FDA.

News release, Novartis.

© 2009 WebMD, LLC. All rights reserved.